Gimv

The Spice Factory is a manufacturer of herbs and spices, catering to customers in Belgium, France, the United Kingdom, and the Netherlands. The company specializes in producing a wide range of herbs, spices, and seasonings, serving both large retailers and food service industries. It offers products under private labels for various brands, as well as its own brand offerings, ensuring a diverse selection to meet the needs of different market segments.

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

Tibbloc specializes in providing turnkey rental solutions for heating, air conditioning, cooling, and related services. Founded in 2007 and headquartered in Saint-Julien-de-Concelles, France, the company operates additional offices in key cities including Paris, Lyon, Nantes, Lille, and Marseille. Tibbloc caters to various sectors, including facility management, engineering, food and beverage, and manufacturing. Its offerings encompass project studies, maintenance, transport and unloading, on-site installation and commissioning, as well as fuel supply and management. The company also provides emergency management services and customizable service options tailored to meet clients' specific technical requirements and budgetary constraints.

Lupine is a company that offers repair services. They change the product in any way but reduce the impact on the environment caused by waste and, at the same time, protect wallet. They develop and produce lamps. The lamp includes all relevant components and the completed repair letter in a package.

Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Onera Health, Inc. specializes in providing innovative sleep diagnostic solutions and services aimed at identifying sleep disorders such as insomnia, sleep apnea, and narcolepsy. Founded in 2017 and headquartered in Palo Alto, California, with a research and development office in Eindhoven, the Netherlands, Onera Health has developed advanced sleep diagnostic patch systems that collect and analyze sleep data. These systems not only enhance the diagnosis of sleep-related ailments but also have potential applications in monitoring various chronic health conditions. By delivering comprehensive sleep test data to healthcare providers, Onera Health aims to improve patient care and reduce healthcare costs, ultimately enhancing the health and quality of life for individuals globally.

ERS is a semiconductor manufacturing company that offers thermal wafer testing and Air-Cool technology services.

Witec is a Contract Design Manufacturer of high-tech equipment and high-end products.

Complement Therapeutics is a preclinical stage biotechnology company focused on developing a precision medicine diagnostic platform to address chronic diseases associated with the dysregulation of the complement system. The company's innovative platform enables the stratification of patients based on their complement-activation profiles, which has the potential to enhance patient selection for clinical trials and serve as an efficacy biomarker in future studies. By offering a more tailored approach to treatment, Complement Therapeutics aims to improve medical outcomes for patients suffering from these chronic conditions.

Mediar Therapeutics is a pre-clinical stage biotechnology company based in Cambridge, Massachusetts, focused on developing antibody-based therapeutics for the treatment of fibrosis. Founded in 2019, the company aims to provide innovative solutions by targeting key fibrotic mediator proteins that contribute to the development of fibrosis in chronically damaged organs. Through its research and development efforts, Mediar seeks to enable medical practitioners to halt and potentially reverse critical fibrosis and related conditions, addressing a significant unmet need in the field of fibrotic diseases.

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

Paleo is a food ingredient company focused on developing innovative, animal-free heme proteins for plant-based meat and fish alternatives. Utilizing precision fermentation, Paleo produces bio-identical heme proteins that are non-GMO and replicate the sensory and nutritional qualities of their animal-derived counterparts. This technology allows businesses to create sustainable food products that not only taste and feel like real meat or fish but also align with ethical considerations by avoiding harm to animals. Through its commitment to bioscience, Paleo aims to enhance the flavor and appeal of plant-based foods, contributing to a healthier and more sustainable food system.

JenaValve Technology, Inc. is a medical device company specializing in the development and manufacturing of transcatheter aortic valve replacement (TAVR) systems designed for patients with severe aortic stenosis and aortic regurgitation. The company's flagship product, the Trilogy Heart Valve System, features a porcine pericardial trileaflet valve mounted on a self-expanding nitinol frame, which allows for both transapical and transfemoral implantation. This innovative system is particularly aimed at high-risk patients and has received CE Mark approval, as well as Breakthrough Device Designation from the U.S. Food and Drug Administration to expedite its review process in the United States. JenaValve operates from its headquarters in Irvine, California, with additional facilities in Munich, Germany, and Leeds, United Kingdom. The company aims to transform the treatment landscape for heart valve diseases through its advanced technologies.

ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.

Variass is a specialist in Electronic Manufacturing Services (EMS) and system supply, primarily serving the defense, medical, water, and industrial sectors. The company develops and produces client-specific electronic and mechatronic products and systems, emphasizing small to medium production runs characterized by high variability and complexity. Variass offers a comprehensive range of services, including product and process development, industrialization, series production and assembly, as well as logistics and lifecycle management. This approach ensures reliable delivery and flexibility, meeting the diverse needs of its clients in various demanding markets.

BioConnection is a European company specializing in the development and manufacturing of injectable biopharmaceutical products. It offers contract manufacturing services to small biopharmaceutical companies, providing access to both small-scale clinical batch production and large-scale commercial manufacturing facilities. The company is equipped with filling and freeze-drying technology and supports clients with sterile drug product development, process validation, and analytical services. BioConnection's extensive network of skilled suppliers and collaborators, including partnerships with experienced organizations, enhances its ability to deliver reliable solutions for clients focusing on personalized medications and clinical trials. By serving as an independent intermediary, BioConnection simplifies the process for companies that may lack the resources or expertise for comprehensive clinical development, ensuring efficient product delivery without the need for clients to seek multiple vendors.

Precirix is a biotechnology company based in Brussels, Belgium, focused on developing radio-immunotherapeutic drugs for cancer treatment. The company's innovative approach leverages the camelid immune system, utilizing antigen-binding fragments to deliver therapeutic radioisotopes directly to targeted receptors on cancer cell surfaces. This targeted delivery system aims to provide personalized cancer therapies, enhancing treatment efficacy while minimizing side effects. Precirix is actively engaged in clinical development, particularly for cancers that express HER2, and is exploring compounds for various other cancer indications. Established in 2014, the company is committed to advancing a new generation of targeted cancer therapies.

GSDI Group specializes in the surface treatment and installation of technical adhesive films, providing comprehensive solutions for renovation, thermal comfort, protection, and decoration. The company serves clients across various sectors, including railway, building, and food. GSDI is distinguished by its extensive installation capabilities in Europe, employing 160 trained applicators who have completed training at the company's approved center. In addition to adhesive films, GSDI offers a range of products such as tarpaulins and varnishes, addressing the diverse needs and challenges faced by its customers in urban cosmetic services.

Topas Therapeutics GmbH is a biotechnology company based in Hamburg, Germany, focused on developing nanoparticle-based therapeutics to address autoimmune diseases, allergies, and anti-drug antibodies. Founded in 2013, the company utilizes its proprietary Topas Particle Conjugates technology platform to induce antigen-specific immune tolerance by leveraging the liver's natural immunological capabilities. Its lead product candidate, TPM203, is currently undergoing clinical testing for pemphigus vulgaris, an orphan disease. Additional programs are being developed for conditions such as celiac disease, Type 1 diabetes, and multiple sclerosis. Topas Therapeutics has established research and collaboration agreements with notable partners, including Eli Lilly and Company and Boehringer Ingelheim, to advance its innovative approaches to immune tolerance. The company aims to address significant unmet medical needs by promoting immune tolerance to blood-borne antigens.

Klotter specializes in the fields of energy technology, automation technology, lightning technology, and building technology.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Verkley is a company focused on constructing and maintaining underground cable and pipeline networks for various sectors, including energy, water, telecommunications, and industrial applications. It provides a range of services, including the laying, mounting, and testing of cables and pipes for gas, water, electricity, heating networks, and public lighting. By leveraging its expertise, Verkley assists clients in optimizing their infrastructure while minimizing waste and reducing environmental impact. The company serves a diverse clientele that includes network companies, industrial firms, and government entities.

Sofatutor GmbH is an educational technology company based in Berlin, Germany, that operates an online learning platform tailored for K-12 students in Europe. Founded in 2008, Sofatutor provides a comprehensive range of resources, including video lessons, practice exercises, worksheets, and homework assistance, covering subjects such as mathematics, physics, English, and chemistry, among others. The platform is designed to support students, teachers, and parents, offering tools that facilitate learning and exam preparation. By providing short video tutorials and personalized tutoring sessions, Sofatutor aims to enhance students' academic performance and foster independent learning. The service is accessible to users in Germany and internationally, catering to a diverse audience of learners.

Kinaset Therapeutics is a therapeutics company dedicated to developing innovative drugs aimed at addressing unmet medical needs, particularly in the field of respiratory health. The company focuses on creating novel therapeutics for patients suffering from intractable diseases, including severe asthma. Kinaset Therapeutics is advancing its lead asset, which employs a unique approach to treating severe asthma, thereby offering healthcare providers a less invasive and more cost-effective treatment option. Through its efforts, Kinaset Therapeutics aims to make a significant positive impact on the lives of individuals affected by challenging respiratory conditions.

SynOx Therapeutics is a clinical-stage biopharmaceutical company based in Dublin, Ireland, that specializes in the development of innovative therapies for cancer. The company's primary focus is on emactuzumab, a humanized monoclonal antibody targeting CSF-1R, aimed at depleting macrophages within tumor tissues. This therapy is being investigated for its potential in treating diffuse tenosynovial giant cell tumors and other macrophage-mediated diseases. Established in 2019, SynOx Therapeutics is backed by experienced investors in the biopharmaceutical field, emphasizing its commitment to addressing the unmet clinical needs of patients and improving their quality of life through advanced treatment options.

Topas Therapeutics GmbH is a biotechnology company based in Hamburg, Germany, focused on developing nanoparticle-based therapeutics to address autoimmune diseases, allergies, and anti-drug antibodies. Founded in 2013, the company utilizes its proprietary Topas Particle Conjugates technology platform to induce antigen-specific immune tolerance by leveraging the liver's natural immunological capabilities. Its lead product candidate, TPM203, is currently undergoing clinical testing for pemphigus vulgaris, an orphan disease. Additional programs are being developed for conditions such as celiac disease, Type 1 diabetes, and multiple sclerosis. Topas Therapeutics has established research and collaboration agreements with notable partners, including Eli Lilly and Company and Boehringer Ingelheim, to advance its innovative approaches to immune tolerance. The company aims to address significant unmet medical needs by promoting immune tolerance to blood-borne antigens.

Televic specializes in providing advanced communication systems tailored for specific markets, including healthcare, education, railways, and conferences. The company manufactures a range of products such as digital on-board services networks, passenger information systems, visual information solutions, rail information systems, and entertainment systems. These offerings ensure seamless and interference-free communication, enhancing user experience in various settings. Televic's commitment to high-tech and high-quality solutions positions it as a leader in its sector, while its strategy to diversify shareholding aims to support further global expansion and strengthen its market presence.

AME is an independent developer and manufacturer of high quality electronic products located in the top technological region.

JenaValve Technology, Inc. is a medical device company specializing in the development and manufacturing of transcatheter aortic valve replacement (TAVR) systems designed for patients with severe aortic stenosis and aortic regurgitation. The company's flagship product, the Trilogy Heart Valve System, features a porcine pericardial trileaflet valve mounted on a self-expanding nitinol frame, which allows for both transapical and transfemoral implantation. This innovative system is particularly aimed at high-risk patients and has received CE Mark approval, as well as Breakthrough Device Designation from the U.S. Food and Drug Administration to expedite its review process in the United States. JenaValve operates from its headquarters in Irvine, California, with additional facilities in Munich, Germany, and Leeds, United Kingdom. The company aims to transform the treatment landscape for heart valve diseases through its advanced technologies.

General Fusion Inc. is a Canadian company focused on the development of commercial Magnetized Target Fusion (MTF), a promising hybrid approach that combines elements of magnetic fusion and inertial confinement fusion. Founded in 2002 and based in Burnaby, the company aims to create utility-scale fusion power plants that can provide clean, safe, and abundant energy. General Fusion is pioneering a patent-pending concept that leverages advancements in MTF, which has seen limited exploration since the 1970s. The company is dedicated to demonstrating and commercializing this innovative energy solution by the end of the decade. It is supported by a network of global energy venture capital firms, industry leaders, and technology innovators, all working to reduce technical risks and accelerate the path to viable fusion energy.

ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.

iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

The Alro Group is a specialises in coating of plastic and metal parts for the automotive sector. Alro Group grown from a small coating company to a large reputed group with several branches in Western and Central Europe, specialized in coating of plastic and metal parts for the automotive sector.

Smart Battery Solutions GmbH, founded in 2010 and based in Kleinostheim, Germany, specializes in the development and manufacturing of lithium-ion battery systems and charging technologies. The company focuses on the low voltage segment, producing a range of products including energy storage systems, chargers, and batteries suitable for various applications. Their offerings cater to the e-mobility sector, serving industries such as e-bikes, e-scooters, watercraft, and drones. Additionally, Smart Battery Solutions provides stationary energy solutions for constant power supply devices, targeting markets in energy production, robotics, nautical science, and healthcare.

Precirix is a biotechnology company based in Brussels, Belgium, focused on developing radio-immunotherapeutic drugs for cancer treatment. The company's innovative approach leverages the camelid immune system, utilizing antigen-binding fragments to deliver therapeutic radioisotopes directly to targeted receptors on cancer cell surfaces. This targeted delivery system aims to provide personalized cancer therapies, enhancing treatment efficacy while minimizing side effects. Precirix is actively engaged in clinical development, particularly for cancers that express HER2, and is exploring compounds for various other cancer indications. Established in 2014, the company is committed to advancing a new generation of targeted cancer therapies.

La Comtoise specializes in developing and supplying customized cheese solutions for the food service industry. The company offers a diverse range of processed cheese products that maintain consistent physicochemical and organoleptic qualities. These products are designed to be integrated into various prepared foods, including breaded escalopes and grilled ham and cheese sandwiches, allowing clients to meet their specific culinary needs.

Medi Markt Service Nord & Ost stands for a need-and situation-appropriate professional supply of medical aids for over 10 years. Our specialties include incontinence, diabetes, stoma, enteral nutrition, tracheostomy, dressing materials, care products and hygiene and disinfection products.

Medi-Markt is the specialist for medical aids and care aids.

Laser 2000 is an independent European supplier specializing in innovative laser and photonics solutions. With over 30 years of experience, the company offers a wide range of products, including lasers, light sources for material processing, measurement equipment, fiber optics, 3D imaging, optical power and energy meters, and cameras. Laser 2000 serves a diverse clientele, including prominent companies and research institutes in sectors such as automation and sensor technology, optical communications, biotech and medicine, automotive, and aerospace. The company's long-standing relationships with customers and suppliers position it as a pioneer in the photonics industry, enabling it to provide tailored consulting and a comprehensive product portfolio for optical technologies.

Impact is a temporary employment agency for specialists in technics, construction and office work. IMPACT is a specialized temporary employment agency with its headquarters in Hasselt. Their main objective? By means of a personal approach, a clear focus, and a great deal of engagement and expertise, they aim to match employers with specialists who are looking for a job in the fields of technics, construction, or office work. Thus, they contribute to the successful growth of enterprises and to the professional satisfaction of the experts who found a job thanks to them.

France Thermes is the organizing entity overseeing its subsidiaries, which include the thermal resorts of Bagnoles de l'Orne in Normandy and Châtel-Guyon in Auvergne, established in 2017. The group specializes in therapeutic treatments utilizing thermal sources, catering to the hydrotherapy sector. It provides water-based therapies and manages healthcare spas designed to address various ailments, such as osteoarthritis and rheumatism. Through its services, France Thermes aims to promote a healthy lifestyle and enhance the well-being of its patients.

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

Wemas Absperrtechnik is a leading manufacturer in Germany specializing in integrated and certified solutions for road safety technology, primarily serving the infrastructure and construction markets. The company's extensive product lineup includes road shut-off devices such as safety barriers, fall arrestors, lights, footplates, and traffic cones. In addition to its core offerings, Wemas also produces various plastic products, including mortar baths, protective devices for the logistics sector, and equipment for equestrian sports. With a dedicated workforce of over 120 employees at its headquarters in Gütersloh, Wemas focuses on delivering high-quality products to wholesalers and service providers, ensuring traffic safety and customer satisfaction.

Arseus Medical is a distributor of medical equipment and consumables focused on serving hospitals, specialists, nursing homes, and home healthcare providers. The company emphasizes efficient diagnostic and therapeutic solutions, offering a range of products including sterile medical gloves, incontinence materials, wound care items, and small instruments. Arseus Medical supports healthcare professionals with systems for patient monitoring and treatment in various care settings, both inside and outside hospitals. By providing innovative solutions and high-quality resources, the company aims to enhance the efficiency and effectiveness of medical practices, allowing professionals to concentrate on patient care. With a strong presence in the Benelux region and dedicated teams, Arseus Medical distinguishes itself through exclusive distribution agreements and a commitment to delivering value to its clients.

MVZ Holding focusses on providing best in class primary medical care and has grown successfully by executing a disciplined expansion strategy. The company currently runs more than 25 medical practices in different regions in Switzerland and plans further expansion within the country.

ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.

ALT Technologies, established in 1935, is a prominent manufacturer of critical airbag components, specializing in covers, wraps, and seals. The company serves nearly all major airbag producers, securing multi-annual contracts that ensure its products are integrated into a wide range of well-known automobile brands globally. In addition to its airbag component production, ALT Technologies also produces tailor-made die-cut and self-adhesive products for various sectors, including automotive and durable goods. The company utilizes materials such as stainless steel and non-woven plastics to deliver innovative and cost-effective solutions that address evolving customer needs in developing new product lines.

Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Breath Therapeutics GmbH, based in Munich, Germany, with an additional office in Menlo Park, California, specializes in the development of drug-aerosol therapeutics aimed at treating bronchiolitis obliterans syndrome and other severe respiratory diseases. Founded in 2016, the company operates as a subsidiary of Zambon S.p.A. Breath Therapeutics focuses on innovative inhalation therapies that combine novel formulations of existing drugs with advanced inhalation technology, specifically targeting rare respiratory conditions with significant unmet medical needs. Their product offerings include a liposomal formulation of cyclosporine A for inhalation, delivered via a high-performance nebulizer that enhances drug concentration in the lungs while reducing systemic exposure. This approach aims to improve treatment efficacy and safety for patients suffering from life-threatening pulmonary diseases.

Itineris specializes in developing and implementing UMAX, a cloud-based customer information and customer relationship management solution tailored for the utilities sector. UMAX utilizes workflow automation and artificial intelligence to facilitate comprehensive management of utility operations, encompassing functions such as revenue collection, asset management, and customer engagement. Built on the Microsoft Dynamics 365 platform and hosted in the Microsoft Azure Cloud, UMAX aims to streamline business processes for utility professionals. Since its founding in 2003, Itineris has established a strong track record in implementing its solutions across various clients, including notable organizations such as De Watergroep in Belgium, Eneco in the Netherlands, and the New York Department of Environmental Protection in the United States. The company focuses on empowering utility professionals to adapt to the evolving landscape of energy and water management.

MEGA International specializes in providing digital transformation software and consulting services aimed at helping organizations manage enterprise complexity. In an era characterized by rapid market changes and evolving regulatory demands, the company offers a comprehensive suite of solutions that empower managers to make informed decisions regarding governance, innovation, cost optimization, and risk management. Their flagship product, HOPEX, integrates various software solutions to assist clients in overcoming corporate governance challenges and executing effective IT strategies and digital transformation initiatives. MEGA International is committed to enhancing business and IT agility for its customers, supported by consulting services recognized for their effectiveness. With a loyal clientele that spans over 40 countries, the company prioritizes customer success as a key driver of its innovation and business strategies.

Acceo is an independent player active in elevator inspection and monitoring services, regulated accessibility audits and energy efficiency audits.

Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients. Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment. Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.

Riaktr is a Belgian scale-up founded in 2009 and backed by first class investors (Fortino, Endeit, GIMV). We started as a service company under the name ‘Real Impact Analytics’. At the time, Big Data was the new big thing, driving important corporate investments. Yet, too often such investments were not yielding the desired returns. Since day one, we pursue a clear mission: leverage the value of telecom data. We do this by starting from the field to build user-centric frameworks driving results. We resist the ‘black box’ principle by putting data at the service of human intelligence and bringing teams together under a collaborative approach. Our brand Riaktr, adopted in 2018, symbolizes our pivot from a services business to a product company. Today our software products address two major questions faced by telcos: - How can I optimize my network CAPEX investments? - How can I optimize my Sales & Distribution operations? Behind the scenes, we are a team of computer scientists, engineers and business consultants based in the heart of Brussels, with a local presence close to our clients in South-Africa and Brazil. We have worked in many countries in Africa, Latin America, the Caribbean and Europe. We work with six of the ten biggest telecom groups to revolutionize the telecom and Consumer Goods industries.

EndoStim, Inc. is a medical device company based in Dallas, Texas, specializing in neurostimulation solutions for the treatment of gastro-esophageal reflux disease (GERD). Founded in 2009, the company has developed a microstimulator technology that restores normal esophageal function by targeting the weak or dysfunctional lower esophageal sphincter (LES) muscle. This innovative approach offers long-term control of reflux symptoms while minimizing the gastrointestinal side effects often associated with traditional anti-reflux surgery. EndoStim is actively conducting clinical trials to secure FDA approval for its therapies, which aim to address not only GERD but also urinary urge incontinence. The company distributes its products across Europe, Asia, and Latin America, focusing on improving the quality of life for patients suffering from these conditions.

Joolz is a Netherlands-based company that specializes in the design and manufacture of premium pushchairs. Known for their award-winning products, Joolz emphasizes quality and ergonomic design, creating stylish and distinctive strollers that cater to the needs of both children and parents. The company's offerings include features such as detachable cradles, hypoallergenic mattresses, and four-wheel suspension, ensuring durability and ease of use for consumers. Joolz is committed to promoting a sustainable and healthy lifestyle for young families, which is evident in their use of reusable packaging and initiatives like the Joolz Birth Forest. Through their innovative products and focus on sustainability, Joolz aims to inspire families to enjoy a positive and enriching life.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Topas Therapeutics GmbH is a biotechnology company based in Hamburg, Germany, focused on developing nanoparticle-based therapeutics to address autoimmune diseases, allergies, and anti-drug antibodies. Founded in 2013, the company utilizes its proprietary Topas Particle Conjugates technology platform to induce antigen-specific immune tolerance by leveraging the liver's natural immunological capabilities. Its lead product candidate, TPM203, is currently undergoing clinical testing for pemphigus vulgaris, an orphan disease. Additional programs are being developed for conditions such as celiac disease, Type 1 diabetes, and multiple sclerosis. Topas Therapeutics has established research and collaboration agreements with notable partners, including Eli Lilly and Company and Boehringer Ingelheim, to advance its innovative approaches to immune tolerance. The company aims to address significant unmet medical needs by promoting immune tolerance to blood-borne antigens.

Itho Daalderop develops and manufactures leading solutions in the fields of heating, tap water, ventilation and control technology. Innovative products and systems that contribute to a healthy, comfortable, energy efficient and affordable indoor climate.

Legallais is a prominent distributor of hardware and building products, specializing in ironmongery, plumbing, and electrical supplies. Primarily serving the French market, the company offers a comprehensive and high-quality range of products tailored for craftsmen, building operators, and maintenance companies. Renowned for its exceptional customer service, Legallais provides multiple ordering options, including mobile, online, and mail, ensuring convenience for its clients. The company also boasts automated logistics that facilitate prompt delivery, typically within 24 hours.

Brakel has been market leader in the area of daylight access, fire safety and ventilation solutions for more than 35 years, with sales in both Europe and further afield. And we offer integral solutions for all kinds of building types comprising: Daylight Skylights, rooflights, skylights and facades Fire safety SHEV systems, fire alarm systems, detection, compartmentation Ventilation Natural ventilation, controlled natural ventilation Maintenance SHEV and ventilation systems, fire alarm systems, glass constructions

Equipe Zorgbedrijven Holding B.V. is a healthcare service organization based in Eindhoven, the Netherlands, specializing in the operation of clinics for specialized surgery. The company manages a network of clinics, providing focused medical services to meet the needs of patients in the region.

Biom'Up, expert in the field of resorbable biomaterials, designs, develops and manufactures unique medical devices based on collagen technology. These innovative and clinically proven products cover many different surgical specialties - orthopaedics, spinal, cardiac, general and maxillo-facial - and improve patient healing by allowing guided regeneration of soft tissues and bone.

JenaValve Technology, Inc. is a medical device company specializing in the development and manufacturing of transcatheter aortic valve replacement (TAVR) systems designed for patients with severe aortic stenosis and aortic regurgitation. The company's flagship product, the Trilogy Heart Valve System, features a porcine pericardial trileaflet valve mounted on a self-expanding nitinol frame, which allows for both transapical and transfemoral implantation. This innovative system is particularly aimed at high-risk patients and has received CE Mark approval, as well as Breakthrough Device Designation from the U.S. Food and Drug Administration to expedite its review process in the United States. JenaValve operates from its headquarters in Irvine, California, with additional facilities in Munich, Germany, and Leeds, United Kingdom. The company aims to transform the treatment landscape for heart valve diseases through its advanced technologies.

CoScale offers a comprehensive performance monitoring platform tailored for production environments, focusing on servers, containers, and applications. The platform provides continuous monitoring and assesses the impact of performance on user experience and essential business metrics. By utilizing automated anomaly detection and contextual insights, CoScale enables proactive management of performance fluctuations that could affect financial outcomes. Its user base includes DevOps engineers, application owners, and business managers, all seeking to enhance digital performance through faster and more reliable websites and applications. This leads to improved user experiences and increased conversion rates, positioning CoScale as a valuable tool for organizations aiming to optimize their digital infrastructure.

Itineris specializes in developing and implementing UMAX, a cloud-based customer information and customer relationship management solution tailored for the utilities sector. UMAX utilizes workflow automation and artificial intelligence to facilitate comprehensive management of utility operations, encompassing functions such as revenue collection, asset management, and customer engagement. Built on the Microsoft Dynamics 365 platform and hosted in the Microsoft Azure Cloud, UMAX aims to streamline business processes for utility professionals. Since its founding in 2003, Itineris has established a strong track record in implementing its solutions across various clients, including notable organizations such as De Watergroep in Belgium, Eneco in the Netherlands, and the New York Department of Environmental Protection in the United States. The company focuses on empowering utility professionals to adapt to the evolving landscape of energy and water management.

United Dutch Breweries is an independent beer group, owning among others Oranjeboom, 3 Horses, Royal Dutch, Atlas – heritage brands, going back to the company’s origin. In addition, UDB sells specialty beers, such as non-alcoholic beers, stout beers and dark malt beverages.

Teads, Inc. is a company that specializes in digital branding through a video advertising supply side platform (SSP) designed for publishers and brands. Founded in 2012 and headquartered in New York, with additional offices in Chicago, Manhattan Beach, and San Francisco, Teads enables clients to create and monetize outstream video advertising inventory via their own sales teams, third parties, and programmatic buying. The company provides an omnichannel platform that facilitates programmatic digital advertising across a global network of premium media, ensuring brand safety and efficiency. By integrating buy-side, sell-side, creative, and data optimization technologies, Teads allows advertisers to access inventory from top publishers while reaching billions of unique users. The platform aims to deliver sustainable business outcomes by combining media, data, and creativity in a curated ecosystem for advertisers and agencies.

EcoChem develops and formulates eco-friendly flame retardants additives, which are mainly used in building & construction, transportation and electronic applications. The company’s products are added to materials such as wood, insulation, textiles or plastics in order to inhibit, suppress or delay flame and smoke production caused by fire. Headquartered in Olen (Belgium), EcoChem operates 2 production facilities located in Willlebroek (Belgium) and in Offenbach (Germany) and is serving clients in 25 countries.

Well Services Group is a comprehensive service provider for the oil and gas industry, catering to both onshore and offshore operations. The company focuses on cleaning and regenerating existing oil and gas wells through the use of coiled tubing. Additionally, it offers installation services for plugs and measurement equipment within these wells. Well Services Group is committed to delivering high-quality services efficiently, utilizing state-of-the-art equipment and a team of experienced personnel. Its flexible operational approach allows for quick responses to customer needs across the petrochemical and energy sectors.

Mackevision Medien Design GmbH, based in Stuttgart, Germany, is a leading provider of Computer Generated Imagery (CGI) and related services. The company specializes in data-driven 3D visualization, animation, and visual effects, offering high-quality image and film production as well as interactive applications. Mackevision's expertise covers a wide range of uses, including online product configurators, digital and print catalogs, virtual showrooms, point-of-sale kiosks, and augmented and virtual reality experiences. Additionally, the company engages in post-production services for broadcast videos and feature films, managing the entire CGI workflow from data preparation to creative design and final output.

Launched in 2007 by entrepreneur and mother of five Nathalie Christen-Genty, MELIJOE.COM is the world’s premier online fashion e-tailer for children ages 0-16. Featuring the latest in childrenswear trends inspired directly by adult runways, MELIJOE.COM is home to some of the industry’s most sought-after labels in kid’s fashion. MELIJOE.COM is above all an international brand, featuring 100% authentic products, speedy worldwide shipping and a website translated in six languages. Thanks to a developed editorial strategy and magazine-inspired web layout, MELIJOE.COM doubles as a digital news outlet for children’s fashion with Le Magazine, and between exclusive shopping edits, childrenswear news, trend reports and in-house photo shoots, MELIJOE.COM is an extra-large world of digital fashion for the smallest of fashionistas.

Thinkstep AG specializes in providing sustainability software, data, and consulting services designed to help organizations achieve operational excellence and navigate sustainability challenges. Their offerings include product sustainability software suites that assist in product design, compliance, and lifecycle engineering, as well as corporate sustainability solutions that streamline reporting, risk management, and resource optimization. Thinkstep also provides energy management tools, supply chain transparency solutions, and life cycle assessment software to support informed decision-making and identify opportunities for improvement. Serving a diverse range of industries, including automotive, construction, consumer goods, and manufacturing, Thinkstep caters to over 2,000 clients globally, including many Fortune 500 companies. Founded in 1991 and based in Leinfelden-Echterdingen, Germany, the company was previously known as PE International GmbH before rebranding in 2015 and now operates as a subsidiary of Sphera Solutions, Inc.

Ablynx is a biopharmaceutical company focused on the discovery and development of Nanobodies®, a unique class of therapeutic proteins derived from single-domain antibody fragments. These innovative proteins are designed to address a variety of serious human diseases, including inflammation, hematology, oncology, and pulmonary conditions. Currently, Ablynx has around 25 projects in its pipeline, with five Nanobodies in clinical development. By combining the advantages of traditional antibodies and small chemical molecules, Ablynx aims to provide new therapeutic options that can significantly improve patient care and outcomes.

JenaValve Technology, Inc. is a medical device company specializing in the development and manufacturing of transcatheter aortic valve replacement (TAVR) systems designed for patients with severe aortic stenosis and aortic regurgitation. The company's flagship product, the Trilogy Heart Valve System, features a porcine pericardial trileaflet valve mounted on a self-expanding nitinol frame, which allows for both transapical and transfemoral implantation. This innovative system is particularly aimed at high-risk patients and has received CE Mark approval, as well as Breakthrough Device Designation from the U.S. Food and Drug Administration to expedite its review process in the United States. JenaValve operates from its headquarters in Irvine, California, with additional facilities in Munich, Germany, and Leeds, United Kingdom. The company aims to transform the treatment landscape for heart valve diseases through its advanced technologies.

Wolf Lingerie is a manufacturer specializing in women's lingerie, focusing on both its proprietary brands, which include Rosy, Sans-Complexe, Billet Doux, Oups, and Jardin Secret, and collections for major retailers and prestigious international brands. The company emphasizes the provision of fashionable and affordable lingerie, with a particular commitment to plus-size offerings. It prioritizes great support, quality finishings, and carefully selected fabrics and cuts, catering to the diverse needs of women in the fashion industry.

Covagen is a biopharmaceutical company focused on developing innovative therapies for inflammatory diseases and cancer. The company specializes in creating bispecific FynomAbs by genetically fusing its proprietary Fynomer binding proteins to antibodies. This unique approach allows for the design of therapeutics with novel mechanisms of action and improved efficacy. Covagen's lead product, COVA322, is aimed at treating inflammatory conditions such as rheumatoid arthritis and psoriatic arthritis. The company was founded in 2007 as a spin-off from ETH Zurich and has established partnerships to enhance its drug development efforts, including a strategic collaboration with Mitsubishi Tanabe for the development of bispecific FynomAbs targeting specific disease-related pairs. A diverse group of investors supports Covagen’s initiatives, providing the necessary resources to advance its innovative therapeutic candidates.

Eurocept, an Ankeveen, the Netherlands-based healthcare company. Founded in 2001 by CEO Mike van Woensel, Eurocept sells specialized medicines and provides medical homecare services. Eurocept Pharmaceuticals is responsible for the registration, marketing, distribution and sale of speciality medicines in the fields of anesthetics, psychiatry, urology, pediatrics and infectious diseases. Eurocept Homecare provides medical specialist homecare and related out-patient medical technology for medicine and food administration.

Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Granted the CE mark in May 2009, Endosense's TactiCath® is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure. It has undergone considerable pre-clinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.

NovoPolymers NV is a company focused on developing and producing sustainable solutions for the photovoltaic market. It specializes in creating front and back encapsulants designed to protect solar cells, which enhance the power output of both crystalline silicon and thin-film solar modules. By optimizing these encapsulants, NovoPolymers aims to add value throughout the photovoltaic supply chain, contributing to the efficiency and sustainability of solar energy production.

JenaValve Technology, Inc. is a medical device company specializing in the development and manufacturing of transcatheter aortic valve replacement (TAVR) systems designed for patients with severe aortic stenosis and aortic regurgitation. The company's flagship product, the Trilogy Heart Valve System, features a porcine pericardial trileaflet valve mounted on a self-expanding nitinol frame, which allows for both transapical and transfemoral implantation. This innovative system is particularly aimed at high-risk patients and has received CE Mark approval, as well as Breakthrough Device Designation from the U.S. Food and Drug Administration to expedite its review process in the United States. JenaValve operates from its headquarters in Irvine, California, with additional facilities in Munich, Germany, and Leeds, United Kingdom. The company aims to transform the treatment landscape for heart valve diseases through its advanced technologies.

Complix is a biopharmaceutical company dedicated to the discovery and development of Alphabodies™, a new class of therapeutics designed to target challenging disease targets. These Alphabodies™ exhibit high affinity for a variety of disease targets, particularly those that are difficult to access with traditional antibodies or other protein-based therapies. The unique stability and versatility of Alphabodies™ allow for alternative non-injectable delivery methods, enhancing their potential in therapeutic applications. The company's pipeline focuses on intracellular targets significant in cancer, autoimmunity, and viral diseases, aiming to combine the effectiveness of biologics with the cell-penetrating capabilities and stability characteristic of small molecules.

Luciad specializes in high-performance geospatial software services designed to support mission-critical operations across various sectors. The company's applications enhance the capabilities of developers and end users through advanced visual analytics, enabling them to leverage real-time location intelligence. Luciad's tools facilitate the development of next-generation geospatial systems applicable in areas such as public safety, smart cities, and defense. By providing intuitive command and control systems, the company allows users to make informed decisions based on dynamic information. Additionally, Luciad offers software solutions that integrate data with geographical information, including maps, satellite imagery, and terrain elevation in multiple formats.

MarcoVasco, (previously known as PlanetVeo) is an online travel agency specialised in organising tailor-made journeys. Founded in 2007 by 3 French entrepreneurs, Marco Vasco quickly became a leader on the online custom holidays market. The company is based in Paris (France) with an office as well in Shanghai (China). The company is profitable since 2010 and our revenues have grown rapidly from 1 million euros in 2008 to 60 million euros in 2013 (organic growth).

Lampiris, an independent supplier of gas, green power and energy services such as insulation, furnace maintenance, wood and pellets for heating, and smart thermostats, has been active in the Belgian energy market since 2005. Lampiris, which currently supplies more than a million accounts, is the third-largest supplier in the residential energy market in Belgium.

Multiplicom specializes in the development of molecular diagnostics products aimed at medical genetics and clinical laboratory applications. The company manufactures molecular diagnostic kits that facilitate the collection of genetic information, enabling personalized treatment options for patients. These kits are particularly valuable for early identification of congenital defects during pregnancy, thereby supporting effective and affordable healthcare solutions. Through its innovative products, Multiplicom strives to enhance access to personalized medicine in the field of genetics.